Immunology Experts

Dr. Glenn Miller

Master Magnetics Inc


Dr. Glenn Miller, Chair of the Scientific Advisory Board and Director, BioMarker Strategies, was most recently Chief Technology Officer and Executive Vice President of MolecularMD, which develops and commercializes specialty molecular diagnostics for oncology applications. He formerly served as Vice President and Head of Strategy for Personalized Medicine and Biomarkers at AstraZeneca. Prior to joining AstraZeneca, he was Vice President and General Manager of Genzyme Analytical Services, a division of Genzyme Genetics, one of the five largest clinical laboratories in the US, which was acquired for $925 million by LabCorp in 2010. Dr. Miller was a key member of the team charged with the divestiture of the Genzyme Genetics business, as well as its subsequent integration into LabCorp. The customers of Genzyme Genetics included 23 of the world’s 25 largest pharmaceutical companies and over 50 biotechnology companies.

Research Interest

After being named Scientific Director of Genzyme Genetics in 2001, Dr. Miller’s responsibilities included positions leading R&D efforts, technology evaluation to identify next-generation testing platforms, and oversight of all academic and scientific collaborations. Dr. Miller was previously responsible for developing pharmacogenetics and biomarker development for a wide variety of drug development programs within Genzyme Corporation.

Global Experts from Antarctica

Global Experts in Subject

Share This Profile